1. Home
  2. HYLN vs AGMB Comparison

HYLN vs AGMB Comparison

Compare HYLN & AGMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyliion Holdings Corp.

HYLN

Hyliion Holdings Corp.

HOLD

Current Price

$3.37

Market Cap

587.6M

ML Signal

HOLD

Logo AgomAb Therapeutics NV American Depositary Shares

AGMB

AgomAb Therapeutics NV American Depositary Shares

HOLD

Current Price

$7.90

Market Cap

576.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYLN
AGMB
Founded
2018
2017
Country
United States
Belgium
Employees
113
N/A
Industry
Construction/Ag Equipment/Trucks
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
587.6M
576.2M
IPO Year
2019
2024

Fundamental Metrics

Financial Performance
Metric
HYLN
AGMB
Price
$3.37
$7.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
7
Target Price
$7.75
★ $37.67
AVG Volume (30 Days)
★ 1.4M
106.8K
Earning Date
11-10-2026
11-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $3,475,000.00
N/A
Revenue This Year
$334.53
N/A
Revenue Next Year
$139.40
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 130.28
N/A
52 Week Low
$1.56
$7.88
52 Week High
$8.49
$17.82

Technical Indicators

Market Signals
Indicator
HYLN
AGMB
Relative Strength Index (RSI) 45.54 31.45
Support Level $3.16 N/A
Resistance Level $4.62 $9.65
Average True Range (ATR) 0.18 0.63
MACD -0.02 0.09
Stochastic Oscillator 47.85 4.62

Price Performance

Historical Comparison
HYLN
AGMB

About HYLN Hyliion Holdings Corp.

Hyliion Holdings Corp designs and develops power generators for stationary and mobile applications and provides R&D service. It provides solutions that enable clean, flexible, and affordable electricity production. The company focuses on delivering distributed power generators that can operate on various fuel sources to future-proof against an ever-changing energy economy. In addition to stationary power solutions, it focuses on mobile applications, including vehicles and marine technologies. Its products and services include: KARNO Power Modules which is a modular, fully enclosed, fuel-agnostic and fully integrated power generating solution.

About AGMB AgomAb Therapeutics NV American Depositary Shares

AgomAb Therapeutics NV is a clinical-stage biopharmaceutical company focused on developing novel disease-modifying therapies for immunology and inflammatory diseases, with an initial focus on chronic fibrotic indications with high unmet medical need. Its product candidates are designed to target established pathways and utilize validated modalities, with a focus on addressing limitations associated with prior treatment approaches. The company's pipeline includes small molecule and antibody product candidates aimed at targets associated with fibrotic diseases. Key candidates include Ontunisertib (AGMB-129) and AGMB-447.

Share on Social Networks: